Form UPLOAD - SEC-generated letter:
SEC Accession No. 0000000000-14-049193
Filing Date
2014-10-01
Accepted
2014-10-01 08:59:22
Documents
1

Document Format Files

Seq Description Document Type Size
1 filename1.pdf LETTER 111082
  Complete submission text file 0000000000-14-049193.txt   154211
Mailing Address 546 FIFTH AVENUE, 14TH FLOOR NEW YORK NY 10036
Business Address 546 FIFTH AVENUE, 14TH FLOOR NEW YORK NY 10036 212-702-7163
RELMADA THERAPEUTICS, INC. (Filed for) CIK: 0001553643 (see all company filings)

EIN.: 455401931 | State of Incorp.: NV | Fiscal Year End: 0630
Type: UPLOAD
SIC: 2834 Pharmaceutical Preparations